Related Experiment Video
Updated: Mar 15, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement
, Kirsten Bibbins-Domingo1, David C Grossman2
1University of California, San Francisco.
JAMA
|September 7, 2016
Summary
Screening for latent tuberculosis infection (LTBI) is recommended for individuals at increased risk. Treatment of LTBI offers moderate benefits in preventing active tuberculosis disease with minimal harms.
Area of Science:
- Public Health
- Preventive Medicine
- Infectious Disease Epidemiology
Background:
- Tuberculosis (TB) is a significant, preventable disease in the U.S.
- Identifying and treating latent tuberculosis infection (LTBI) is key to reducing TB transmission, illness, and death.
- Preventing progression from LTBI to active TB disease is a primary public health goal.
Purpose of the Study:
- To provide an updated recommendation from the U.S. Preventive Services Task Force (USPSTF) on screening for LTBI.
- To inform primary care practices on current guidelines for LTBI screening.
Main Methods:
- Systematic review of evidence on LTBI screening in asymptomatic adults in primary care.
- Inclusion of evidence from the earliest available database records.
Main Results:
- Accurate screening tests for LTBI are available.
- Treatment for LTBI provides a moderate benefit in preventing active disease progression.
- The harms associated with screening and treatment for LTBI are considered small.
Conclusions:
- The USPSTF recommends screening for LTBI in populations identified as being at increased risk.
- This recommendation is designated as a 'B' recommendation, indicating high certainty of moderate net benefit.
Related Concept Videos
Pulmonary Tuberculosis IV
612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612
Pulmonary Tuberculosis V
730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K

